Cite
HARVARD Citation
Strohbehn, G. et al. (2021). COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia. Clinical pharmacology & therapeutics. 109 (3), pp. 688-696. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Strohbehn, G. et al. (2021). COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia. Clinical pharmacology & therapeutics. 109 (3), pp. 688-696. [Online].